longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

PATH

PATH
----

LongbridgeAI

Weekly Recap | UiPath -16.31%, earnings beat but stock sells off

Weekly Review
Sep 5, 2026 at 07:42 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

UiPath (PATH) dropped 16.31% this week to close at $15.19 on Friday, while the S&P 500 added 0.09%. The stock underperformed the benchmark by roughly 16.4 percentage points. The week started on a steady note, with the stock holding above $18 through Monday and Tuesday. Thursday’s session touched a weekly high of $18.83, but Friday opened sharply lower and never recovered. The stock fell as much as 16% intraday to $14.77 before settling near $15. Weekly amplitude came in at 22.

The Week

UiPath (PATH) dropped 16.31% this week to close at $15.19 on Friday, while the S&P 500 added 0.09%. The stock underperformed the benchmark by roughly 16.4 percentage points. The week started on a steady note, with the stock holding above $18 through Monday and Tuesday. Thursday’s session touched a weekly high of $18.83, but Friday opened sharply lower and never recovered. The stock fell as much as 16% intraday to $14.77 before settling near $15. Weekly amplitude came in at 22.44%, and Friday’s volume jumped well above the recent average. Average daily volume for the week ran about 7.63% above the 60-day median.

Key Events

The dominant event this week was the fiscal Q2 2027 earnings report released after the close on September 3. Revenue rose 13% year over year to $410 million, beating estimates. Net income climbed to $36.09 million, ARR reached $1.938 billion, and the company raised its full-year guidance. Yet the stock sold off hard on Friday. Reports pointed to a few overlapping factors: despite the revenue beat, investors appeared to question the pace of AI monetisation, and several headlines tied the drop to a weak full-year revenue forecast. The CEO’s sale of roughly $22.5 million in shares also surfaced repeatedly in pre-market and intraday coverage. The company filed an 8-K on the same day as the earnings release.

Analyst Ratings

As of September 4, 21 firms cover UiPath: 1 rates it buy, 1 overweight, 17 hold, 1 underweight, 0 sell, and 1 has no opinion. The consensus rating is hold, with a consensus target of $16.4675, about 8.41% above the $15.19 close. The target range is wide, from a low of $10.98 to a high of $22.00, pointing to meaningful dispersion. Within the systems software industry, UiPath ranks around 18th out of 47 names by analyst rating.

The Week Ahead

The first full week after the earnings report will see the market continue to digest the gap between the raised full-year guidance and the softer full-year revenue forecast. On the macro calendar, the NFIB Small Business Optimism Index arrives on September 8. September 10 brings initial jobless claims, final demand PPI, existing home sales, and the 10-year Treasury auction, which could shift expectations around rates and feed directly into how long-duration growth names like software are valued.

In Short

UiPath’s week lays two signals side by side: revenue beat estimates and guidance was raised, yet the stock fell 16.31%. Analysts remain collectively neutral—17 of 21 rate it hold—while the consensus target still sits above the spot price. Friday’s heavy selling and the CEO share sale added a sentiment layer on top of the fundamental story. The question going forward is how the market prices the pace of AI monetisation within the automation narrative, and how long macro data keeps pressing on valuations for long-duration growth equities.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Login to unlock2,487characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

UiPath

UiPath

USPATH

-4.22%

Tradr 2X Long PATH Daily ETF

Tradr 2X Long PATH Daily ETF

USPATX